Cellyan Biotechnology Co., LtdHKPDEarnings & Financial Report
Nasdaq
HKPD Q2 2025 Key Financial Metrics
Revenue
$11.1M
Gross Profit
$1.9M
Operating Profit
$1.0M
Net Profit
$13
Gross Margin
17.2%
Operating Margin
9.3%
Net Margin
0.0%
YoY Growth
N/A
Financial Flow
Cellyan Biotechnology Co., Ltd Q2 2025 Financial Summary
Cellyan Biotechnology Co., Ltd reported revenue of $11.1M for Q2 2025, with a net profit of $13 (0.0% margin). Cost of goods sold was $9.2M, operating expenses totaled $878.6K.
Key Financial Metrics
| Total Revenue | $11.1M |
|---|---|
| Net Profit | $13 |
| Gross Margin | 17.2% |
| Operating Margin | 9.3% |
| Report Period | Q2 2025 |
Income Statement
| Q2 2025 | |
|---|---|
| Revenue | $11.1M |
| YoY Growth | N/A |
Balance Sheet
| Q2 2025 | |
|---|---|
| Assets | N/A |
| Liabilities | N/A |
| Equity | N/A |
Cash Flow
No data available for this period